Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication February 6, 2019
- Published online October 1, 2019.
Article Versions
- Latest version (March 15, 2019 - 04:00).
- Latest version (June 7, 2019 - 08:30).
- Latest version (August 1, 2019 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 Free online via JRheum Full Release option
Author Information
- Laure Gossec,
- Vibeke Strand,
- Clare Proudfoot,
- Chieh-I Chen,
- Sophie Guillonneau,
- Toshio Kimura,
- Hubert van Hoogstraten,
- Erin Mangan and
- Matthew Reaney⇑
- From the Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique (UMRS 1136), GRC-UPMC 08 (EEMOIS); Rheumatology Department, Hôpital Pitié Salpêtrière, AP-HP, Paris, France; Stanford University, Palo Alto, California, USA; Sanofi, Guildford, UK; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA; Sanofi, Paris, France; Sanofi, Bridgewater, New Jersey, USA.
- L. Gossec, MD, PhD, Sorbonne Université and Rheumatology Department, Hôpital Pitié Salpêtrière, Institut Pierre Louis d’Epidémiologie et de Santé Publique (UMRS 1136), GRC-UPMC 08 (EEMOIS); V. Strand, MD, Stanford University; C. Proudfoot, PhD, Novartis; C.I. Chen, MPH, Regeneron Pharmaceuticals Inc.; S. Guillonneau, MSc, Sanofi; T. Kimura, MSc, Regeneron Pharmaceuticals Inc.; H. van Hoogstraten, MD/PhD, Sanofi; E. Mangan, PhD, Regeneron Pharmaceuticals Inc.; M. Reaney, MSc, formerly of Sanofi.
- Address correspondence to M. Reaney, 3 Forbury Place, 23 Forbury Road, Reading, RG1 3JH, UK. E-mail: matthew.reaney{at}iqvia.com